Stock Analysis
Incyte Corporation (INCY) Stock Analysis
Incyte Corporation (INCY) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Incyte Corporation (INCY) currently has an AIQ Score of 71/100, indicating a bullish setup. Quality is the strongest factor at 90/100. Value is the weakest current factor at 54/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
INCY at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $125.01 |
| AIQ Score | 71/100 |
| Overall View | Bullish |
| Technical Analysis Consensus | Buy |
| Market Cap | $24.54B |
| P/E Ratio | 16.27 |
| Forward P/E | — |
| EPS | $2.92 |
| Revenue TTM | $1.67B |
| Dividend Yield | 0.00% |
| Beta | 0.77 |
| Volume | 1.19M |
| 52-week range | $81.09-$132.60 |
| RSI 14 | 60.09 |
| 50-Day SMA | $119.54 |
| 200-Day SMA | $104.37 |
| Analyst Price Target | $121.79 |
| Next Earnings | Oct 27, 2026 |
INCY
OverviewINCY Stock Analysis Summary
Incyte Corporation (INCY) currently has an AIQ Score of 71/100/100, indicating a bullish setup. Quality is the strongest factor at 90/100/100. Value is the weakest current factor at 54/100/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bullish regime, INCY has AIQ Score of 71/100 with Quality base of 90/100 and fading Value at 54/100. Wait for component alignment before adding exposure.
Quality (90/100) leads while Value (54/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 1.45% stock move · INCY classified in Biotechnology.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is INCY Bullish or Bearish Right Now?
INCY currently has a bullish overall setup. Quality is the strongest factor at 90/100, while Value is weakest at 54/100. The current evidence suggests a constructive setup.
- - Quality is supportive at 90/100.
- - Momentum is constructive at 68/100.
- - Risk Resilience is supportive at 75/100.
- - Price is +4.57% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (25 vs 13).
- - Analyst target implies -2.58% downside from the latest quote.
Current Consensus
INCY's Technical Analysis Consensus is currently Buy, with 25 buy, 7 neutral, and 13 sell votes. INCY's 14-day RSI is 60.09, which places the stock in a constructive momentum range. INCY's beta is 0.77, indicating lower market sensitivity than the broad market.
What Changed in INCY?
Recent score-change history is not available in the current snapshot. The page still shows the latest market-close evidence and timestamps.
What Would Change the INCY Outlook?
The current bullish outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
INCY Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
INCY Fundamentals
INCY valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
INCY Technical Analysis
INCY technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
INCY Stock Catalysts
Track INCY earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
INCY Dividend Analysis
INCY dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
INCY Financial Data
INCY revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
INCY Risk Analysis
INCY volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
INCY Stock News
INCY stock news, market tone, recent headlines, and catalyst context.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 2, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Value and quality should explain the score, not sit behind it.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for INCY
Scenario Analysis
AIQ Scenario Builder
Incyte Corporation (INCY) Stock Analysis
Incyte Corporation has an AIQ Score of 71/100 in a Bullish regime. Quality is strongest at 90/100.
The main conflict is that quality leads at 90/100 while value lags at 54/100. Review the supporting factors together before drawing a conclusion from any single score.
Beta is 0.77, below market sensitivity. Current price is $125.01 and RSI (14) is 60.1.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | INCY is in a Bullish AIQ regime with score 71/100. |
| Signal Conflict | The primary conflict is that quality leads at 90/100 while value lags at 54/100. |
| Factor Evidence | Momentum 68/100 · Value 54/100 · Quality 90/100 · Risk 75/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Pass | Quality is the strongest factor at 90/100. |
| Timing | Pass | Momentum is 68/100 and RSI (14) is 60.1. |
| Regime fit | Pass | INCY is in a Bullish regime at 71/100. |
| Risk control | Pass | Risk factor is 75/100 with beta 0.77 and annual volatility 33.02%. |
| Conflict | Wait | Current conflict: quality leads at 90/100 while value lags at 54/100. |
| AIQ Score | 71/100/100 |
| Price | $125.01 |
| Beta | 0.77 |
| RSI (14) | 60.1 |
Compare with Similar Stocks
Portfolio Implication
Related Links
Related Links
INCY Stock FAQ
What is INCY stock price today?
Incyte Corporation's current stock price is $125.01. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is INCY bullish or bearish right now?
INCY's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is INCY's market cap?
INCY's market cap is $24.54B based on the latest completed market-close snapshot from Sep 1, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is INCY's current P/E ratio?
INCY's current P/E ratio is 16.27 based on the latest completed market-close snapshot from Sep 1, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is INCY's RSI?
INCY's 14-day RSI is 60.09 based on the latest completed market-close snapshot from Sep 1, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is INCY above its 50-day and 200-day moving averages?
INCY is 4.57% from its 50-day SMA and 19.77% from its 200-day SMA based on the latest completed market-close snapshot from Sep 1, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is INCY's next earnings date?
INCY's next earnings date is currently listed as Oct 27, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does INCY pay a dividend?
INCY's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 1, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.